Immunotherapy With N 803, ETBX-071, and M-CENK in Combination With Radiation for Participants With High-Risk Prostate Cancer.
Clinical trial NCT06765954 · WITHDRAWN
Trial details
- NCT number
- NCT06765954
- Sponsor
- ImmunityBio, Inc.
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-12-01
- Primary completion
- 2031-01-31
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.